Operator`s manual
1 of 16
Director Signature__________________________________ Date___________________
Clinical Laboratories
Point of Care 
Testing 
ACCU-CHEK INFORM II BLOOD GLUCOSE DETERMINATION
I. PURPOSE AND PRINCIPLE
The Accu-Chek Inform II meter is used for Quantitative determination of glucose in 
whole blood specimens. The enzyme on the test strip, mutant variant of quinoprotein 
glucose dehydrogenase converts the glucose in the blood sample to gluconolactone. 
This reaction creates a harmless electrical current that the meter interprets as a glucose 
concentration in mg/dL.
The system is calibrated with venous blood containing various glucose concentrations 
and is calibrated to deliver plasma-like results. The reference values are obtained using 
a validated test method. This test method is referenced to the hexokinase method and 
is traceable to an NIST standard.
II. SCOPE
The Accu-Chek Inform II meter is used for monitoring blood glucose levels in hospitals, 
ambulatory practices, and home care settings. It is used in both adult, pediatric, neonate 
patient populations, however, it’s accuracy and precision in critically ill patients has not 
been evaulated. The test is to be used for monitoring glucose levels and should not be 
used for diagnosis.
III. PERSONNEL
Intended for use by clinical personnel who have received training and demonstrated 
competency in this procedure. In the hospital setting, this includes Clinical Laboratory 
Scientists, Registered Nurses, Nurse Practitioners, Physician Assistants, Physicians, 
Respiratory Tech. In the ambulatory setting, this includes the aforementioned 
personnel as well as Medical Assistants, Licensed Vocational Nurses and other 
licensed Technologists.
IV. SPECIMEN REQUIREMENTS AND INTERFERENCES
A. Use capillary whole blood samples obtained from fingerstick. For children under 
12 months of age, sample is obtained from heel stick. Fingerstick and heel stick 
samples must be tested immediately. Do not use plasma, serum or Cord Blood 
samples.
B. Wipe away the first drop of blood with gauze and use the second free-flowing 
drop of blood from the fingerstick site for testing. 
C. Venous, arterial or neonatal blood sample collected in lithium heparin are also 
acceptable. Sample must be tested within 30 minutes of drawing to minimize the
effects of glycolysis.
Rev 1, Ver 2, 9/9/2013










